Welcome to Nucleus Network
Your Trusted Clinical Trial Partner
With over 20 years’ experience in conducting early phase clinical trials for Biotechnology and Pharmaceutical companies, Nucleus Network understands the evolving landscape of drug development.
Our Unique Offering
Nucleus Network is the only Phase 1 clinical research organization in the world to have Phase 1 facilities located in Australia and the USA. We are Australia’s largest Phase 1 clinical research organization and one of the few specialized units in the USA capable of delivering Phase 1 hepatic and renal clinical trials.
Our Proven Expertise
In excess of
Phase 1 clinical trials conducted
Annually conducting
Clinical Pharmacology trials across three clinics
Including
true first-in-human studies annually
Over
Clinical trial beds
Hosted over
independent sponsor audits, including FDA and EMA regulatory inspections
Access to over
total population across Brisbane and Melbourne (Australia)
As well as
total population across Minneapolis-Saint Paul (USA)
Database of
qualified participants
Our Advantages
Nucleus Network is uniquely positioned to help administer your clinical trial with our four key advantages:
Specialization
We are unmatched in our capabilities, experience and ability to offer specialized Phase 1 facilities for early phase clinical trial design. Each of our Phase 1 facilities have focused areas of specialization and extensive internal and external capabilities to support the complex requirements of Phase 1 clinical trials.
Read moreExpertise
Our Phase 1 facilities are supported by a highly trained and dedicated team of medical personnel (FRACP), including clinical pharmacologists, oncologists, nephrologists and infectious disease physicians. Specialized Phase 1 facilities also ensure our teams are highly experienced in particular trial designs, and can be considered specialists rather than generalists in their approach.
Read moreMulti-Country, Multi-Site Location
Working in two of the world’s most attractive markets for Phase 1 clinical trials – Australia and the USA – Nucleus’ multi-country presence is designed to support you, whatever your clinical development strategy. Our three clinics are strategically co-located within prominent hospitals and leading medical research precincts to support safety and accessing specialist PD biomarkers.
Read moreQuality
The data generated from Nucleus Network is used to support IND and NDA regulatory filings for the USA FDA. Data is also used for EMA, PMDA and Health Canada regulatory filings. We have 100% pass rate on independent regulatory inspections, including FDA and EMA.
Read more